MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$18,510K
Net Income
-$312K
Net Profit Margin
-1.69%
EPS
-$0.01
Unit: Thousand (K) dollars
Revenue Breakdown
product revenue, net
Cutia Supply Agreement
Royalties On Sales Of Amzeeq By ...
Revenue Breakdown
Emrosi
Qbrexza
Accutane
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
18,510
15,961
16,079
17,631
Cost of goods sold - (excluding amortization of acquired intangible assets)
6,143
6,218
5,603*
5,755
Amortization of acquired intangible assets
969
1,126
1,065
1,064
Research and development
54
-
-9*
287
Selling, general and administrative
10,888
10,109
9,863
12,054
Total operating expenses
18,054
17,453
16,522
19,160
Income (loss) from operations
456
-1,492
-443
-1,529
Interest income
154
157
148
154
Interest expense
906
892
933
937
Foreign exchange transaction losses
-1
-3
-19
-3
Total other expense
-753
-738
-804
-786
Loss before income taxes
-297
-2,230
-1,247
-2,315
State
-
-
15
-
Total current
-
-
15*
-
Federal
-
-
-556*
-
State
-
-
-11*
-
Total deferred
-
-
-567*
-
Valuation allowance
-
-
552*
-
Income tax expense
15
-
0
-
Net loss
-312
-2,230
-1,247
-2,315
Basic EPS
-0.01
-0.08
-0.046
-0.09
Diluted EPS
-0.01
-0.08
-0.046
-0.09
Basic Average Shares
27,493,693
27,305,028
27,130,932
24,959,114
Diluted Average Shares
27,493,693
27,305,028
27,130,932
24,959,114
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
product revenue, net
$17,839K
product revenue, net
$17,839K
Cutia Supply
Agreement
$635K
Royalties On Sales Of
Amzeeq By Cutia
$36K
product revenue, net
$17,839K
other revenue
$671K
Net loss
-$312K
(91.78%↑ Y/Y)
Total revenue
$18,510K
(23.33%↑ Y/Y)
Loss before income
taxes
-$297K
(92.05%↑ Y/Y)
Income tax expense
$15K
(-75.00%↓ Y/Y)
Income (loss) from
operations
$456K
(115.86%↑ Y/Y)
Total operating
expenses
$18,054K
(0.94%↑ Y/Y)
Total other expense
-$753K
(12.44%↑ Y/Y)
Interest income
$154K
(11.59%↑ Y/Y)
Selling, general and
administrative
$10,888K
(-8.37%↓ Y/Y)
Cost of goods sold -
(excluding amortization of...
$6,143K
(24.38%↑ Y/Y)
Amortization of acquired
intangible assets
$969K
(-8.93%↓ Y/Y)
Research and development
$54K
Interest expense
$906K
(-3.31%↓ Y/Y)
Foreign exchange
transaction losses
-$1K
(98.36%↑ Y/Y)
Buy us a coffee
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)